Beijing Ditan Hospital

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Source

• Recruiting

  Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

  NCT06923280· Source

• Not yet recruiting

  Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

  NCT07007286· Source

• Recruiting

  Research on Clinical Recovery and Maintenance Strategies for CHB

  NCT06803368· Source

• Enrolling by invitation

  Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

  NCT06777173· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B4 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Liver and biliary tract cancer1 recruiting

Researchers

No researcher is linked here yet.